Potential strategies including small-molecule modulators, proteolysis targeting chimera (PROTAC), programmable m6A-editing systems, compounds targeting the regulatory machinery of ALKBH5, as well as gene therapy, could be applied to manipulate ALKBH5-mediated m6A demethylation in cancer (Table 4; Fig. 5). Here, ALKBH5 is linked to cancer.